Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae.
about
Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae.Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860
Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tigecycline-Amikacin Combinati ...... oducing Klebsiella pneumoniae.
@en
Tigecycline-Amikacin Combinati ...... oducing Klebsiella pneumoniae.
@nl
type
label
Tigecycline-Amikacin Combinati ...... oducing Klebsiella pneumoniae.
@en
Tigecycline-Amikacin Combinati ...... oducing Klebsiella pneumoniae.
@nl
prefLabel
Tigecycline-Amikacin Combinati ...... oducing Klebsiella pneumoniae.
@en
Tigecycline-Amikacin Combinati ...... oducing Klebsiella pneumoniae.
@nl
P2093
P2860
P356
P1476
Tigecycline-Amikacin Combinati ...... oducing Klebsiella pneumoniae.
@en
P2093
Beibei Liang
Chuanqi Wei
Chufei Zhou
Junchang Cui
Youning Liu
P2860
P356
10.3389/FMICB.2016.01304
P577
2016-08-19T00:00:00Z